TY  - JOUR
T1  - SOy isoflavone supplementation in menopausal women—reply
AU  - Levis S, Xu P, Doerge DR, Krischer J
Y1  - 2011/12/12
N1  - 10.1001/archinternmed.2011.583
JO  - Archives of Internal Medicine
SP  - 2067
EP  - 2068
VL  - 171
IS  - 22
N2  - 
A total of 66 randomized participants did not complete the study (23 in the soy isoflavone group and 43 in the placebo group).1 A comparable number of women in each group reported moving out of state, having a sick family member, a new job, or a desire to eat soy products as the reason to discontinue their participation. Although there was a marked difference in the proportion of participants who were no longer interested in participating in the study or were lost to follow-up (16 [19%] in the soy isoflavone group and 30 [34%] in the placebo group), we did not find any objective measures that could explain this difference.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.583
UR  - http://dx.doi.org/10.1001/archinternmed.2011.583
ER  -